CAS No.301856-25-7 | 5,7-difluoro-1h-indole
CAS No.301856-25-7 | 5,7-difluoro-1h-indole
CAS No.301856-25-7 | 5,7-difluoro-1h-indole
CAS No.301856-25-7 | 5,7-difluoro-1h-indole
+
  • CAS No.301856-25-7 | 5,7-difluoro-1h-indole
  • CAS No.301856-25-7 | 5,7-difluoro-1h-indole
  • CAS No.301856-25-7 | 5,7-difluoro-1h-indole
  • CAS No.301856-25-7 | 5,7-difluoro-1h-indole

CAS No.301856-25-7 | 5,7-difluoro-1h-indole

Name:5,7-difluoro-1h-indole CAS No.301856-25-7 MF:C8H5F2N MW:153.13 Purity:97% Package: 5g,25g,100g,500g,1kg,25kg Worldwide Delivery

Categories:

Pharmaceutical Intermediates

Product introduction

Introduction and application of CAS No.301856-25-7 | 5,7-difluoro-1h-indole

5,7-Difluoro-1H-indole is a metabolically stable, potent inhibitor of influenza A virus polymerase. It has been shown to be active in vivo against influenza A and B virus replication. The compound is undergoing clinical development for the treatment of influenza.

5,7-Difluoro-1H-indole inhibits the activity of the influenza virus polymerase by binding to the enzyme’s basic protein and blocking its active site. This prevents viral replication and can lead to therapeutic benefits in patients with influenza A or B infections.

 

Synonyms:

5,7-DIFLUOROINDOLE;

5,7-difluoroinde;

1H-Indole,5,7-difluoro-(9CI);

5,7-Difluoro-1H-Indole;1H-Indole, 5,7-difluoro-;

SWF-101;SW-101;

5,8-Difluoroindole

 

Specification of CAS No.301856-25-7 | 5,7-difluoro-1h-indole

 

ITEMS

SPECIFICATION

CAS No.

301856-25-7

MF

C8H5F2N

MW

153.13

Boiling point

253.2±20.0 °C(Predicted)

Density

1.388±0.06 g/cm3(Predicted)

acidity coefficient(pKa)

14.71±0.30(Predicted)

Package of CAS No.301856-25-7 | 5,7-difluoro-1h-indole

Package:100g; 500g; 1kg; 25kg;bulk package

Transportation: by courier/ by air/ by sea

Related Articles of CAS No.301856-25-7 | 5,7-difluoro-1h-indole

Design, synthesis, and biological evaluation of novel indoles targeting the influenza PB2 cap binding region

DC McGowan, W Balemans, W Embrechts… - Journal of medicinal …, 2019 - ACS Publications

… Specifically, a 5,7-difluoroindole derivative 11a was identified as a potent and metabolically

stable influenza inhibitor. 11a demonstrated a favorable oral pharmacokinetic profile and in …

 

Key words:

Related Products

Related Products

Inquiry

SUBMIT